Citation Impact
Citing Papers
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
2013 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Primary Ovarian Insufficiency
2009
Sexual Desire in Trans Persons: Associations with Sex Reassignment Treatment
2013
Major depressive disorder
2016 Standout
Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?
2008
Metabotropic glutamate receptor 5: a target for migraine therapy
2016
Contraceptive failure in the United States
2011 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
2018 StandoutNobel
CGRP as the target of new migraine therapies — successful translation from bench to clinic
2018
Obesity in menopause – our negligence or an unfortunate inevitability?
2017 Standout
Sexual Problems and Distress in United States Women
2008 Standout
The contribution of SHBG to the variation in HOMA‐IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women
2011
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
2017
Depression in adolescence
2012 Standout
Sexual dysfunction in men and women with endocrine disorders
2007
Contraceptive Technology
2021 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial
2015
Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
2019
Breast Cancer in Female-to-Male Transsexuals: Two Cases With a Review of Physiology and Management
2011
Hormonal contraceptives for contraception in overweight or obese women
2013
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial
2020
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Antiglucocorticoid treatments for mood disorders
2015
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
2017
Hormonal contraceptives for contraception in overweight or obese women
2016
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Assessment and Management of Women's Sexual Dysfunctions: Problematic Desire and Arousal
2005
A second trigeminal CGRP receptor: function and expression of the AMY 1 receptor
2015
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
2018
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Current contraceptive status among women aged 15-44: United States, 2011-2013.
2014 Standout
Works of Robin Kroll being referenced
Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder
2001
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
2014
Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol
2015
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
2008
The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol
2009
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women
2006
Testosterone transdermal patch (TTP) significantly improved sexual function in naturally menopausal women in a large Phase III study
2004
Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial
2016
Treatment of premenstrual disorders.
2006